title: DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors.
abstract: DNA oligonucleotides containing a strong topoisomerase I cleavage site were used to study the DNA cleavage and strand transferase activities of calf thymus topoisomerase I (top1) in the absence and presence of camptothecin. A partially single-stranded oligonucleotide with only two nucleotides on the 3' side of the cleavage site (positions +1 and +2) was cleaved at the same position as the corresponding duplex oligonucleotide. However, cleavage in the absence of camptothecin was more pronounced than in the duplex oligonucleotide and was only partially reversible in the presence of 0.5 M NaCl, consistent with release of the dinucleotide 3' to the top1 break. Another reaction took place generating a larger DNA fragment which resulted from religation (strand transfer) of the 5'-hydroxyl terminus of the non-scissile DNA strand to the 3' end of the top1-linked oligonucleotide after loss of the +1 and +2 nucleotides. Top1 religation activity appeared efficient since only the last 5' base of the single-stranded DNA acceptor was complementary to the 3' tail of the donor DNA. Religation was not detectable with a double-stranded DNA acceptor, which is consistent with the persistence of top1-induced DNA double-strand breaks in camptothecin-treated cells. Camptothecin and other top1 inhibitors enhanced cleavage in both the partially single-stranded and the duplex oligonucleotides, indicating that they did not inhibit the induction of top1-mediated DNA cleavage but primarily blocked the religation step of the enzyme catalytic cycle. The top1 DNA strand transferase activity was reversibly inhibited by camptothecin and several derivatives, as well as saintopin. These results are discussed in terms of camptothecin-induced DNA recombinations.
authors.affiliation: Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4255, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Pommier
authors.forename: J
authors.initials: J
authors.lastname: Jenkins
authors.forename: G
authors.initials: G
authors.lastname: Kohlhagen
authors.forename: F
authors.initials: F
authors.lastname: Leteurtre
mesh_terms: D000818:Animals; D001483:Base Sequence; D002166:Camptothecin / Q000494:pharmacology*; D002417:Cattle; D004249:DNA Damage; D004260:DNA Repair; D004277:DNA, Single-Stranded / Q000378:metabolism; D004791:Enzyme Inhibitors; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D009838:Oligodeoxyribonucleotides / Q000737:chemistry; D011995:Recombination, Genetic / Q000187:drug effects; D059004:Topoisomerase I Inhibitors
chemical_list: D004277:DNA, Single-Stranded; D004791:Enzyme Inhibitors; D009838:Oligodeoxyribonucleotides; D059004:Topoisomerase I Inhibitors; D002166:Camptothecin